Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001179110-22-000401 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-01-11	2022-01-07	PTCT	Utter Christine Marie	SVP, CAO, Fin	S - Sale	$38.53	-747	16.3K	-4%	-$28.8K
D	2022-01-11	2022-01-07	PTCT	Utter Christine Marie	SVP, CAO, Fin	A - Grant	$0.00	+11.6K	27.9K	+71%	$0
D	2022-01-11	2022-01-07	PTCT	Utter Christine Marie	SVP, CAO, Fin	A - Grant	$0.00	+43.5K	43.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-07	S	D	747	$38.53	16,253	D	—	—	(F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs. (F2) Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.
2	Common	Common Stock	2022-01-07	A	A	11,600	$0.00	27,853	D	—	—	(F3) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
3	Derivative	Stock Option (Right to Buy)	2022-01-07	A	A	43,500	$0.00	43,500	D	$38.10 · — to 2032-01-06	43,500 Common Stock	(F4) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.